Concordance between clinical, genomic, and AI-based risk stratification in prostate cancer. Article

Bastos, Bruno R, Cusnir, Mike, Schwartz, Michael A et al. (2026). Concordance between clinical, genomic, and AI-based risk stratification in prostate cancer. . JOURNAL OF CLINICAL ONCOLOGY, 44(7_suppl), 388-388. 10.1200/jco.2026.44.7_suppl.388

cited authors

  • Bastos, Bruno R; Cusnir, Mike; Schwartz, Michael A; Blaustein, Arnold S; Bhandari, Akshay; Weizer, Alon; Barrientos, Jacqueline Claudia; Nieder, Alan; Borregales, Leonardo; Simkins, Aron; Goya Balaguer, Evelyn; Brauchle, Yelida; Gligich, Oleg

authors

publication date

  • March 1, 2026

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Cancer
  • Cancer Genomics
  • Clinical Research
  • Genetics
  • Human Genome
  • Machine Learning and Artificial Intelligence
  • Patient Safety
  • Precision Medicine
  • Prostate Cancer
  • Urologic Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 388

end page

  • 388

volume

  • 44

issue

  • 7_suppl